Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 14 studies | 23% ± 8% | |
brain | 11 studies | 33% ± 16% | |
lung | 10 studies | 28% ± 8% | |
eye | 8 studies | 25% ± 7% | |
liver | 5 studies | 27% ± 13% | |
kidney | 4 studies | 20% ± 3% | |
bone marrow | 4 studies | 24% ± 7% | |
uterus | 3 studies | 34% ± 11% | |
intestine | 3 studies | 30% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 5235.35 | 1445 / 1445 | 100% | 52.15 | 183 / 183 |
lung | 100% | 5777.97 | 578 / 578 | 100% | 46.48 | 1155 / 1155 |
breast | 100% | 5240.78 | 459 / 459 | 100% | 65.68 | 1117 / 1118 |
brain | 100% | 4169.89 | 2638 / 2642 | 100% | 63.07 | 705 / 705 |
prostate | 100% | 4326.53 | 245 / 245 | 100% | 43.88 | 500 / 502 |
uterus | 100% | 5683.29 | 170 / 170 | 100% | 45.44 | 457 / 459 |
bladder | 100% | 5299.24 | 21 / 21 | 99% | 43.50 | 501 / 504 |
thymus | 100% | 5642.40 | 653 / 653 | 99% | 55.90 | 601 / 605 |
ovary | 100% | 6039.11 | 180 / 180 | 99% | 25.75 | 427 / 430 |
adrenal gland | 100% | 8168.50 | 258 / 258 | 99% | 45.71 | 227 / 230 |
intestine | 100% | 5630.17 | 966 / 966 | 98% | 42.13 | 519 / 527 |
pancreas | 99% | 3071.42 | 326 / 328 | 99% | 41.77 | 176 / 178 |
stomach | 100% | 4140.27 | 359 / 359 | 98% | 38.95 | 280 / 286 |
kidney | 100% | 3359.87 | 89 / 89 | 98% | 35.76 | 879 / 901 |
skin | 100% | 4943.90 | 1808 / 1809 | 95% | 46.39 | 448 / 472 |
liver | 97% | 1820.74 | 219 / 226 | 86% | 17.77 | 349 / 406 |
blood vessel | 100% | 5467.55 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 53.25 | 29 / 29 |
muscle | 100% | 3417.17 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 5490.19 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 44.35 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 13.78 | 1 / 1 |
adipose | 100% | 5139.88 | 1203 / 1204 | 0% | 0 | 0 / 0 |
heart | 97% | 3219.57 | 838 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 73% | 3760.78 | 678 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 70% | 19.76 | 56 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006325 | Biological process | chromatin organization |
GO_0006281 | Biological process | DNA repair |
GO_0016479 | Biological process | negative regulation of transcription by RNA polymerase I |
GO_0000183 | Biological process | rDNA heterochromatin formation |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0006346 | Biological process | DNA methylation-dependent heterochromatin formation |
GO_0006974 | Biological process | DNA damage response |
GO_1990830 | Biological process | cellular response to leukemia inhibitory factor |
GO_1905213 | Biological process | negative regulation of mitotic chromosome condensation |
GO_0006338 | Biological process | chromatin remodeling |
GO_0031507 | Biological process | heterochromatin formation |
GO_0006334 | Biological process | nucleosome assembly |
GO_0045945 | Biological process | positive regulation of transcription by RNA polymerase III |
GO_0045740 | Biological process | positive regulation of DNA replication |
GO_0045943 | Biological process | positive regulation of transcription by RNA polymerase I |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0006275 | Biological process | regulation of DNA replication |
GO_0006352 | Biological process | DNA-templated transcription initiation |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0140374 | Biological process | antiviral innate immune response |
GO_0043596 | Cellular component | nuclear replication fork |
GO_0005730 | Cellular component | nucleolus |
GO_0110016 | Cellular component | B-WICH complex |
GO_0008623 | Cellular component | CHRAC |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005677 | Cellular component | chromatin silencing complex |
GO_0001650 | Cellular component | fibrillar center |
GO_0090536 | Cellular component | NoRC complex |
GO_0090535 | Cellular component | WICH complex |
GO_0005721 | Cellular component | pericentric heterochromatin |
GO_0016590 | Cellular component | ACF complex |
GO_0016589 | Cellular component | NURF complex |
GO_0000793 | Cellular component | condensed chromosome |
GO_0035861 | Cellular component | site of double-strand break |
GO_0031213 | Cellular component | RSF complex |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0004386 | Molecular function | helicase activity |
GO_0042393 | Molecular function | histone binding |
GO_0140751 | Molecular function | histone octamer slider activity |
GO_0005524 | Molecular function | ATP binding |
GO_0031491 | Molecular function | nucleosome binding |
GO_0140658 | Molecular function | ATP-dependent chromatin remodeler activity |
GO_0008094 | Molecular function | ATP-dependent activity, acting on DNA |
GO_0005515 | Molecular function | protein binding |
GO_0016887 | Molecular function | ATP hydrolysis activity |
Gene name | SMARCA5 |
Protein name | SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5 (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin A5) (EC 3.6.4.-) (Sucrose nonfermenting protein 2 homolog) (hSNF2H) Uncharacterized protein SMARCA5 |
Synonyms | SNF2H WCRF135 |
Description | FUNCTION: Helicase that possesses intrinsic ATP-dependent nucleosome-remodeling activity . Catalytic subunit of ISWI chromatin-remodeling complexes, which form ordered nucleosome arrays on chromatin and facilitate access to DNA during DNA-templated processes such as DNA replication, transcription, and repair; this may require intact histone H4 tails . Within the ISWI chromatin-remodeling complexes, slides edge- and center-positioned histone octamers away from their original location on the DNA template . Catalytic activity and histone octamer sliding propensity is regulated and determined by components of the ISWI chromatin-remodeling complexes . The BAZ1A/ACF1-, BAZ1B/WSTF-, BAZ2A/TIP5- and BAZ2B-containing ISWI chromatin-remodeling complexes regulate the spacing of nucleosomes along the chromatin and have the ability to slide mononucleosomes to the center of a DNA template in an ATP-dependent manner . The CECR2- and RSF1-containing ISWI chromatin-remodeling complexes do not have the ability to slide mononucleosomes to the center of a DNA template . Binds to core histones together with RSF1, and is required for the assembly of regular nucleosome arrays by the RSF-5 ISWI chromatin-remodeling complex . Involved in DNA replication and together with BAZ1A/ACF1 is required for replication of pericentric heterochromatin in S-phase . Probably plays a role in repression of RNA polymerase I dependent transcription of the rDNA locus, through the recruitment of the SIN3/HDAC1 corepressor complex to the rDNA promoter (By similarity). Essential component of the WICH-5 ISWI chromatin-remodeling complex (also called the WICH complex), a chromatin-remodeling complex that mobilizes nucleosomes and reconfigures irregular chromatin to a regular nucleosomal array structure . The WICH-5 ISWI chromatin-remodeling complex regulates the transcription of various genes, has a role in RNA polymerase I transcription (By similarity). Within the B-WICH complex has a role in RNA polymerase III transcription . Mediates the histone H2AX phosphorylation at 'Tyr-142', and is involved in the maintenance of chromatin structures during DNA replication processes (By similarity). Essential component of NoRC-5 ISWI chromatin-remodeling complex, a complex that mediates silencing of a fraction of rDNA by recruiting histone-modifying enzymes and DNA methyltransferases, leading to heterochromatin formation and transcriptional silencing (By similarity). . |
Accessions | Q4W5H1 ENST00000283131.4 Q4W5G3 O60264 |